Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The MRC Anatomical Neuropharmacology Unit at the University of Oxford (MRC ANU) closed on the 31 March after 30 years of world leading research on the complex networks of the brain. From 1 April, the ANU becomes  the Medical Research Council Brain Network Dynamics Unit at the University of Oxford (MRC BNDU). 

Our goal is to understand and exploit the interactions between nerve cells that are critical for brain functions, with a special focus on the brain circuits underlying movement and memory...we aim to develop and deliver novel therapies that specifically target the disturbed circuit interactions arising in disease.
- Professor Peter Brown

The new unit, led by director Professor Peter Brown, will build on the previous unit's success, using animal models and patients to understand brain circuitry in some of the most prevalent and debilitating brain disorders such as Parkinson’s disease, memory disorders and Alzheimer’s disease.

The MRC BNDU will be uniquely multidisciplinary and integrate research programmes covering clinical, experimental and computational neuroscience in both the Department of Pharmacology and the Nuffield Department of Clinical Neurosciences.

Read more...

Similar stories

Royal Commission Industrial Fellowship for Andrei-Claudiu Roibu with F. Hoffmann-La Roche Ltd

Mapping brain network activity from structural connectivity using deep learning

Researchers awarded Wellcome Innovator Grant to investigate role of brainstem nucleus in human consciousness

Researchers at Oxford University have received a prestigious Wellcome Innovator Grant for investigating the role of the pedunculopontine nucleus (PPN) – a brainstem nucleus – in human consciousness.

Blood lipoprotein levels linked to future risk of amyotrophic lateral sclerosis

Greater understanding of the role of lipoproteins could support screening and efforts to develop treatments.

Alexander Davies wins top UKRI Future Leaders Fellowship

Alex is one of eight Oxford University academics who have been awarded significant financial funding from the UKRI Future Leaders Fellowships Scheme

New study on link between autoimmunity and pain

Patients with autoantibodies which target neuronal proteins can have pain as an under-recognised clinical manifestation.